Solara Lively Pharma meets USFDA’s inspection at its Visakhapatnam facility

Solara Lively Pharma Sciences Ltd has introduced that the USFDA has accomplished the inspection at its multipurpose API manufacturing facility in Visakhapatnam, Andhra Pradesh.

The inspection established that the location is in an “acceptable state of compliance” with zero type 483 inspectional observations.

The Visakhapatnam facility is a inexperienced discipline mission unfold over 40 acres and has amenities for the manufacture of Ibuprofen API.

• Additionally learn: Dr Reddy’s, Solar Pharma, Aurobindo recall merchandise within the US

Poorvank Purohit, MD & CEO mentioned “That is the second US FDA inspection we’ve undergone at this website. We stay agile to the rising necessities on high quality and compliance, and I’m assured that we are going to maintain our high quality tradition and anchor it additional.”